HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plano Contact Lens Warning Indicates Regulation As Devices, Not Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

An FDA warning on the potential health risks of non-corrective (plano), decorative contact lenses signals that the products are unlikely to be regulated as cosmetics, as at least one manufacturer had hoped

You may also be interested in...



Plano Lens Cosmetics Classification Countered In Boozman-Waxman Bill

Legislation co-sponsored by Reps. Henry Waxman (D-Calif.) and House optometrist John Boozman (R-Ark.) targets alleged loopholes created by FDA's recent decision to regulate noncorrective contact lenses as cosmetics rather than medical devices

Plano Lens Cosmetics Classification Countered In Boozman-Waxman Bill

Legislation co-sponsored by Reps. Henry Waxman (D-Calif.) and House optometrist John Boozman (R-Ark.) targets alleged loopholes created by FDA's recent decision to regulate noncorrective contact lenses as cosmetics rather than medical devices

Colored Contact Lens Regulation A Priority For New Commissioner – Kennedy

The appropriateness of regulating colored noncorrective contact lenses as cosmetics could be addressed quickly by FDA Commissioner nominee Mark McClellan, MD/PhD

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel